The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Toxicol.
Sec. Computational Toxicology and Informatics
Volume 6 - 2024 |
doi: 10.3389/ftox.2024.1474397
This article is part of the Research Topic Models, methods, and tools for improved mechanistic understanding in nanotoxicology View all articles
An Adverse Outcome Pathway for Food Nanomaterial-induced Intestinal Barrier Disruption
Provisionally accepted- 1 European Commission, Joint Research Centre (JRC), Ispra, Lombardia, Italy
- 2 Independent Researcher, Ispra, Italy
- 3 Institute of Experimental and Clinical Research (IREC), UCLouvain, Brussels, Belgium
Introduction: Ingestion of nanomaterials (NMs) might impair intestinal barrier, but the underlying mechanisms remain evasive, and evidence is not systematically gathered or produced. A mechanisticbased approach would be instrumental to assess if relevant NMs disrupt intestinal barrier to support NM risk assessment in the food sector.Methods: Here, we developed an adverse outcome pathway (AOP) based on biological plausibility and by leveraging existing information of an existing NM relevant AOP leading to hepatic outcomes. We then extracted the current evidence existing in the literature for a targeted selection of NMs with high food sector relevance, namely ZnO, CuO, FeO, SiO2, Ag NMs and nanocellulose.We propose a new AOP (AOP530) that starts with endocytic lysosomal uptake leading to lysosomal disruption inducing mitochondrial dysfunction. Mitochondrial impairments can lead to cell injury/death and disrupt the intestinal barrier. The evidence collected supports that those food NMs can be taken up by intestinal cells and indicates that intestinal barrier disruption by Ag, CuO, SiO2 NMs might occur whilst only few studies support that outcome for FeO, ZnO. Lysosomal disruption and mitochondrial dysfunction are rarely evaluated. For nanocellulose, none of the studies report toxicrelated events.Collecting the existing scientific evidence supporting our AOP linking NM uptake to intestinal barrier impairments allowed us to highlight current evidence gaps but also data inconsistencies. Those latter could be associated with the variety of stressors, biological systems and KE-related assays used in the different studies, calling for further harmonized methodologies and production of mechanistic evidence in the safety regulatory assessment of NMs in the food sector. a mis en forme : Français (Belgique)
Keywords: Food, nanomaterial, AOP, Endocytosis, Intestinal barrier disruption
Received: 01 Aug 2024; Accepted: 19 Nov 2024.
Copyright: © 2024 Stanco, Lipsa, Bogni, Bremer-Hoffmann and Clerbaux. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Laure-Alix Clerbaux, Institute of Experimental and Clinical Research (IREC), UCLouvain, Brussels, Belgium
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.